Can Postpartum Depression Be Prevented With Care
21 de marzo de 2022 actualizado por: Gulsen Eryilmaz, Ataturk University
Can Postpartum Depression Be Prevented With Care Provided To Primiparas Using Levine's Conservation Model: Single-Blind Randomized Controlled Experimental Study
This study was designed to eliminate postpartum insomnia and fatigue and reduce the risk of postpartum depression through the maintenance of structural, personal, and social integrity with holistic care under the guidance of Levine's conservation model for primiparous puerperal women who experience fatigue and are at risk of developing depression.
: A single-blind pretest-posttest randomized controlled study.
Women were called to the hospital on the 7th postpartum day and randomly assigned by a computer program to either the intervention group (n=56) or the control group (n=56).
Participants did not know which group they were in.
Descripción general del estudio
Estado
Terminado
Descripción detallada
A nursing care program was prepared for the intervention group under the guidance of Levine's conservation model. This program was applied with 7 home visits between the 8th and 80th postpartum days. Face-to-face training and training booklets were provided in home visits. As of the fourth home visit, Pilates exercises were performed. The women in the control group received routine care. Pretest and posttest data were collected with a personal data sheet, visual analogue scale for fatigue, Postpartum Physical Symptom Severity Scale, Postpartum Sleep Quality Scale, Edinburgh Postpartum Depression Scale, and Postpartum Support Scale.
Sleep quality improved for the primiparous puerperal women of the intervention group. They had reduced postpartum fatigue and increased energy; maintained their structural, personal, and social integrity; and had decreased risk of developing postpartum depression with the holistic care provided (all p<0.001). A negative correlation was detected between the support subscale posttest total score from the Postpartum Support Scale and the posttest scores of the Edinburgh Postpartum Depression Scale for the women of the intervention group (r=-0.303; p<0.05)
Tipo de estudio
Intervencionista
Inscripción (Actual)
112
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Erzurum, Pavo, 25240
- AtaturkU
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 35 años (Adulto)
Acepta Voluntarios Saludables
Sí
Géneros elegibles para el estudio
Femenino
Descripción
Inclusion Criteria:
- primiparous;
- reading and understanding Turkish;
- normal term delivery;
- no risky situations during pregnancy or delivery;
- high score (≥65 points) from the Visual Analogue Scale to Evaluate Fatigue Severity (VAS-F),
- score of ≥12 points from the Edinburgh Postpartum Depression Scale (EPDS);
- episiotomy;
- hemoglobin value of at least 10.0 mg/dL;
- no current or past history of psychiatric illness.
Exclusion Criteria:
- inability to communicate
- unwillingness to participate in the research.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: The intervention group
To reduce postpartum depression among the primiparous puerperal women in the intervention group, and a nursing care program was implemented under the guidance of Levine's model.
This program was applied with 7 home visits between the 8th and 80th postpartum days.
Face-to-face training and training booklets were provided in home visits.
As of the fourth home visit, Pilates exercises were performed.
|
Face-to-face training and training booklets were provided in home visits.
As of the fourth home visit, Pilates exercises were performed.
|
|
Sin intervención: The control group
In the control group women received routine postpartum care.
No interventions were conducted other than routine postpartum care.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Visual Analogue Scale to Evaluate Fatigue Severity Scores
Periodo de tiempo: 1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
The highest score that can be obtained for the fatigue subdimension is 130 and the lowest score is 0. The highest score that can be obtained from the energy subdimension is 50 and the lowest score is 0. Higher scores on items measuring fatigue and lower scores on items measuring energy indicate that the severity of fatigue is high.
|
1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
|
Edinburgh Postpartum Depression Scale Scores
Periodo de tiempo: 1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
The highest score that can be obtained from the scale is 30.
A score of 12 or more indicates that the individual is at risk of depression.
|
1- 7th day after giving birth, Time Frame: 2- postpartum 12th week
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
The Postpartum Support Scale Scores
Periodo de tiempo: 1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
The lowest score that can be obtained from the scale is 0 and the highest score is 238.
The higher the total score, the greater the need for support and the greater the support that needs to be received.
|
1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
|
the Postpartum Sleep Quality Scale Scores
Periodo de tiempo: 1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
The lowest and highest possible scores are respectively 0 and 56.
Higher scores indicate lower sleep quality.
|
1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
|
The Postpartum Physical Symptom Severity Scale Scores
Periodo de tiempo: 1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
Total possible scores range between 0 and 54.
Higher scores obtained from this scale indicate higher severity of postpartum physical symptoms.
|
1- postpartum 8th day Time Frame: 2- Postpartum 12th week
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de julio de 2019
Finalización primaria (Actual)
1 de abril de 2020
Finalización del estudio (Actual)
9 de marzo de 2021
Fechas de registro del estudio
Enviado por primera vez
9 de marzo de 2022
Primero enviado que cumplió con los criterios de control de calidad
21 de marzo de 2022
Publicado por primera vez (Actual)
24 de marzo de 2022
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
24 de marzo de 2022
Última actualización enviada que cumplió con los criterios de control de calidad
21 de marzo de 2022
Última verificación
1 de marzo de 2022
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- AtaturkU-GulsenEryilmaz-001
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
There is not a plan to make IPD available
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .